Paul Tudor Jones Boston Scientific Corp Transaction History

Tudor Investment Corp Et Al

$200 Billion
Q3 2025

A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Boston Scientific Corp stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 660,186 shares of BSX stock, worth $67.8 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

660,186

Previous 650,620 1.47%

Holding current value

$67.8 Million

Previous $69.9 Million 7.77%

% of portfolio

0.03%

Previous 0.16%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$97.03 - $108.14 $928,188 - $1.03 Million	9,566 Added 1.47%	660,186 $64.5 Million
Q2 2025 Aug 14, 2025	BUY	$89.7 - $107.41 $35.4 Million - $42.4 Million	394,489 Added 154.02%	650,620 $69.9 Million
Q1 2025 May 15, 2025	BUY	$89.38 - $106.18 $22.9 Million - $27.2 Million	256,131 New	256,131 $25.8 Million
Q3 2024 Nov 14, 2024	BUY	$72.96 - $84.0 $23 Million - $26.5 Million	315,270 Added 2169.19%	329,804 $27.6 Million
Q2 2024 Aug 14, 2024	SELL	$67.33 - $77.71 $9.57 Million - $11 Million	-142,175 Reduced 90.73%	14,534 $1.12 Million
Q1 2024 May 15, 2024	SELL	$57.6 - $68.62 $2.72 Million - $3.24 Million	-47,279 Reduced 23.18%	156,709 $10.7 Million
Q4 2023 Feb 14, 2024	SELL	$48.64 - $57.81 $5.09 Million - $6.05 Million	-104,697 Reduced 33.92%	203,988 $11.8 Million
Q3 2023 Nov 15, 2023	BUY	$50.19 - $54.68 $3.64 Million - $3.96 Million	72,449 Added 30.67%	308,685 $16.3 Million
Q2 2023 Aug 14, 2023	BUY	$49.72 - $54.64 $876,762 - $963,521	17,634 Added 8.07%	236,236 $12.8 Million
Q1 2023 May 15, 2023	BUY	$45.09 - $50.03 $9.86 Million - $10.9 Million	218,602 New	218,602 $10.9 Million
Q1 2022 May 16, 2022	BUY	$40.9 - $45.1 $466,955 - $514,906	11,417 Added 68.14%	28,173 $1.25 Million
Q4 2021 Feb 14, 2022	BUY	$38.07 - $44.87 $249,586 - $294,167	6,556 Added 64.27%	16,756 $712,000
Q3 2021 Nov 15, 2021	BUY	$41.23 - $45.88 $420,545 - $467,976	10,200 New	10,200 $443,000
Q2 2021 Aug 16, 2021	SELL	$38.58 - $44.24 $818,821 - $938,949	-21,224 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$35.27 - $39.67 $321,062 - $361,116	9,103 Added 75.1%	21,224 $820,000
Q4 2020 Feb 16, 2021	SELL	$33.15 - $41.97 $2.29 Million - $2.9 Million	-69,180 Reduced 85.09%	12,121 $436,000
Q3 2020 Nov 16, 2020	BUY	$34.44 - $42.23 $1.67 Million - $2.04 Million	48,401 Added 147.12%	81,301 $3.11 Million
Q2 2020 Aug 14, 2020	SELL	$30.19 - $39.11 $406,417 - $526,498	-13,462 Reduced 29.04%	32,900 $1.16 Million
Q1 2020 May 15, 2020	BUY	$25.83 - $45.71 $1.2 Million - $2.12 Million	46,362 New	46,362 $1.51 Million
Q2 2019 Aug 14, 2019	SELL	$34.91 - $42.98 $2.14 Million - $2.63 Million	-61,225 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$32.91 - $40.75 $2.01 Million - $2.49 Million	61,225 New	61,225 $2.35 Million
Q3 2018 Nov 14, 2018	SELL	$32.83 - $38.63 $1.01 Million - $1.18 Million	-30,623 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$26.84 - $34.32 $105,642 - $135,083	3,936 Added 14.75%	30,623 $1 Million
Q1 2018 May 15, 2018	SELL	$25.2 - $28.54 $4.26 Million - $4.82 Million	-168,980 Reduced 86.36%	26,687 $729,000
Q4 2017 Feb 14, 2018	BUY	$24.79 - $29.8 $4.85 Million - $5.83 Million	195,667	195,667 $4.85 Million

Others Institutions Holding BSX

# of Institutions

1,950

Shares Held

1.26B

Call Options Held

10.9M

Put Options Held

8.94M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $147B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account